241 related articles for article (PubMed ID: 32760139)
1. Selective Upregulation of CTLA-4 on CD8+ T Cells Restricted by HLA-B*35Px Renders them to an Exhausted Phenotype in HIV-1 infection.
Elahi S; Shahbaz S; Houston S
PLoS Pathog; 2020 Aug; 16(8):e1008696. PubMed ID: 32760139
[TBL] [Abstract][Full Text] [Related]
2. Impact of a single HLA-A*24:02-associated escape mutation on the detrimental effect of HLA-B*35:01 in HIV-1 control.
Murakoshi H; Koyanagi M; Akahoshi T; Chikata T; Kuse N; Gatanaga H; Rowland-Jones SL; Oka S; Takiguchi M
EBioMedicine; 2018 Oct; 36():103-112. PubMed ID: 30249546
[TBL] [Abstract][Full Text] [Related]
3. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection.
Altfeld M; Addo MM; Rosenberg ES; Hecht FM; Lee PK; Vogel M; Yu XG; Draenert R; Johnston MN; Strick D; Allen TM; Feeney ME; Kahn JO; Sekaly RP; Levy JA; Rockstroh JK; Goulder PJ; Walker BD
AIDS; 2003 Dec; 17(18):2581-91. PubMed ID: 14685052
[TBL] [Abstract][Full Text] [Related]
4. The differential ability of HLA B*5701+ long-term nonprogressors and progressors to restrict human immunodeficiency virus replication is not caused by loss of recognition of autologous viral gag sequences.
Migueles SA; Laborico AC; Imamichi H; Shupert WL; Royce C; McLaughlin M; Ehler L; Metcalf J; Liu S; Hallahan CW; Connors M
J Virol; 2003 Jun; 77(12):6889-98. PubMed ID: 12768008
[TBL] [Abstract][Full Text] [Related]
5. Correlates of spontaneous viral control among long-term survivors of perinatal HIV-1 infection expressing human leukocyte antigen-B57.
Tang Y; Huang S; Dunkley-Thompson J; Steel-Duncan JC; Ryland EG; St John MA; Hazra R; Christie CD; Feeney ME
AIDS; 2010 Jun; 24(10):1425-35. PubMed ID: 20539088
[TBL] [Abstract][Full Text] [Related]
6. High responsiveness of HLA-B57-restricted Gag-specific CD8+ T cells in vitro may contribute to the protective effect of HLA-B57 in HIV-infection.
Jansen CA; Kostense S; Vandenberghe K; Nanlohy NM; De Cuyper IM; Piriou E; Manting EH; Miedema F; van Baarle D
Eur J Immunol; 2005 Jan; 35(1):150-8. PubMed ID: 15593302
[TBL] [Abstract][Full Text] [Related]
7. STING Ligand-Mediated Priming of Functional CD8
Kuse N; Akahoshi T; Takiguchi M
J Virol; 2021 Jul; 95(16):e0069921. PubMed ID: 34076478
[TBL] [Abstract][Full Text] [Related]
8. Rapid progressing allele HLA-B35 Px restricted anti-HIV-1 CD8+ T cells recognize vestigial CTL epitopes.
Willberg CB; Garrison KE; Jones RB; Meiklejohn DA; Spotts G; Liegler TJ; Ostrowski MA; Karlsson AC; Hecht FM; Nixon DF
PLoS One; 2010 Apr; 5(4):e10249. PubMed ID: 20422053
[TBL] [Abstract][Full Text] [Related]
9. Viral replication capacity as a correlate of HLA B57/B5801-associated nonprogressive HIV-1 infection.
Navis M; Schellens I; van Baarle D; Borghans J; van Swieten P; Miedema F; Kootstra N; Schuitemaker H
J Immunol; 2007 Sep; 179(5):3133-43. PubMed ID: 17709528
[TBL] [Abstract][Full Text] [Related]
10. Targeting of a CD8 T cell env epitope presented by HLA-B*5802 is associated with markers of HIV disease progression and lack of selection pressure.
Ngumbela KC; Day CL; Mncube Z; Nair K; Ramduth D; Thobakgale C; Moodley E; Reddy S; de Pierres C; Mkhwanazi N; Bishop K; van der Stok M; Ismail N; Honeyborne I; Crawford H; Kavanagh DG; Rousseau C; Nickle D; Mullins J; Heckerman D; Korber B; Coovadia H; Kiepiela P; Goulder PJ; Walker BD
AIDS Res Hum Retroviruses; 2008 Jan; 24(1):72-82. PubMed ID: 18275350
[TBL] [Abstract][Full Text] [Related]
11. HLA-E-restricted CD8
La Manna MP; Orlando V; Prezzemolo T; Di Carlo P; Cascio A; Delogu G; Poli G; Sullivan LC; Brooks AG; Dieli F; Caccamo N
Am J Respir Cell Mol Biol; 2020 Apr; 62(4):430-439. PubMed ID: 31697586
[TBL] [Abstract][Full Text] [Related]
12. Preservation of T cell proliferation restricted by protective HLA alleles is critical for immune control of HIV-1 infection.
Horton H; Frank I; Baydo R; Jalbert E; Penn J; Wilson S; McNevin JP; McSweyn MD; Lee D; Huang Y; De Rosa SC; McElrath MJ
J Immunol; 2006 Nov; 177(10):7406-15. PubMed ID: 17082660
[TBL] [Abstract][Full Text] [Related]
13. Immunological Control of HIV-1 Disease Progression by Rare Protective HLA Allele.
Zhang Y; Chikata T; Kuse N; Murakoshi H; Gatanaga H; Oka S; Takiguchi M
J Virol; 2022 Nov; 96(22):e0124822. PubMed ID: 36326273
[TBL] [Abstract][Full Text] [Related]
14. HLA-E-restricted, Gag-specific CD8
Yang H; Rei M; Brackenridge S; Brenna E; Sun H; Abdulhaqq S; Liu MKP; Ma W; Kurupati P; Xu X; Cerundolo V; Jenkins E; Davis SJ; Sacha JB; Früh K; Picker LJ; Borrow P; Gillespie GM; McMichael AJ
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33766848
[TBL] [Abstract][Full Text] [Related]
15. Differential clade-specific HLA-B*3501 association with HIV-1 disease outcome is linked to immunogenicity of a single Gag epitope.
Matthews PC; Koyanagi M; Kløverpris HN; Harndahl M; Stryhn A; Akahoshi T; Gatanaga H; Oka S; Juarez Molina C; Valenzuela Ponce H; Avila Rios S; Cole D; Carlson J; Payne RP; Ogwu A; Bere A; Ndung'u T; Gounder K; Chen F; Riddell L; Luzzi G; Shapiro R; Brander C; Walker B; Sewell AK; Reyes Teran G; Heckerman D; Hunter E; Buus S; Takiguchi M; Goulder PJ
J Virol; 2012 Dec; 86(23):12643-54. PubMed ID: 22973023
[TBL] [Abstract][Full Text] [Related]
16. Greater CD8+ TCR heterogeneity and functional flexibility in HIV-2 compared to HIV-1 infection.
Lopes AR; Jaye A; Dorrell L; Sabally S; Alabi A; Jones NA; Flower DR; De Groot A; Newton P; Lascar RM; Williams I; Whittle H; Bertoletti A; Borrow P; Maini MK
J Immunol; 2003 Jul; 171(1):307-16. PubMed ID: 12817012
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive screening for human immunodeficiency virus type 1 subtype-specific CD8 cytotoxic T lymphocytes and definition of degenerate epitopes restricted by HLA-A0207 and -C(W)0304 alleles.
Currier JR; deSouza M; Chanbancherd P; Bernstein W; Birx DL; Cox JH
J Virol; 2002 May; 76(10):4971-86. PubMed ID: 11967314
[TBL] [Abstract][Full Text] [Related]
18. A nonprogressive clinical course in HIV-infected individuals expressing human leukocyte antigen B57/5801 is associated with preserved CD8+ T lymphocyte responsiveness to the HW9 epitope in Nef.
Navis M; Schellens IM; van Swieten P; Borghans JA; Miedema F; Kootstra NA; van Baarle D; Schuitemaker H
J Infect Dis; 2008 Mar; 197(6):871-9. PubMed ID: 18279072
[TBL] [Abstract][Full Text] [Related]
19. Protective HIV-specific CD8+ T cells evade Treg cell suppression.
Elahi S; Dinges WL; Lejarcegui N; Laing KJ; Collier AC; Koelle DM; McElrath MJ; Horton H
Nat Med; 2011 Jul; 17(8):989-95. PubMed ID: 21765403
[TBL] [Abstract][Full Text] [Related]
20. TCR clonotypes modulate the protective effect of HLA class I molecules in HIV-1 infection.
Chen H; Ndhlovu ZM; Liu D; Porter LC; Fang JW; Darko S; Brockman MA; Miura T; Brumme ZL; Schneidewind A; Piechocka-Trocha A; Cesa KT; Sela J; Cung TD; Toth I; Pereyra F; Yu XG; Douek DC; Kaufmann DE; Allen TM; Walker BD
Nat Immunol; 2012 Jun; 13(7):691-700. PubMed ID: 22683743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
